Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:alsoKnownAs |
gptkb:syndrome_X
gptkb:insulin_resistance_syndrome |
| gptkbp:associatedWith |
insulin resistance
chronic inflammation |
| gptkbp:cause |
heart attack
kidney disease stroke early death |
| gptkbp:characterizedBy |
high blood pressure
high blood sugar low HDL cholesterol abdominal obesity high triglycerides |
| gptkbp:component |
gptkb:HDL_cholesterol
blood pressure triglycerides waist circumference fasting glucose |
| gptkbp:definedIn |
gptkb:NCEP_ATP_III_criteria
gptkb:WHO_criteria IDF criteria |
| gptkbp:diagnosedBy |
clinical criteria
blood tests |
| gptkbp:firstDescribed |
gptkb:Gerald_Reaven
1988 |
| https://www.w3.org/2000/01/rdf-schema#label |
metabolic syndrome
|
| gptkbp:ICD-10_code |
E88.81
|
| gptkbp:managedBy |
gptkb:metformin
gptkb:food exercise weight loss statins antihypertensive drugs |
| gptkbp:prevalence |
increases with age
20-25% of adults higher in people with obesity |
| gptkbp:relatedTo |
gptkb:polycystic_ovary_syndrome
atherosclerosis nonalcoholic fatty liver disease |
| gptkbp:riskFactor |
gptkb:cardiovascular_disease
gptkb:type_2_diabetes genetic factors smoking sedentary lifestyle unhealthy diet |
| gptkbp:symptom |
often asymptomatic
|
| gptkbp:treatment |
gptkb:drug
lifestyle modification |
| gptkbp:bfsParent |
gptkb:BMI
gptkb:polycystic_ovary_syndrome |
| gptkbp:bfsLayer |
5
|